307 related articles for article (PubMed ID: 26317353)
1. Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation.
Filograna R; Civiero L; Ferrari V; Codolo G; Greggio E; Bubacco L; Beltramini M; Bisaglia M
PLoS One; 2015; 10(8):e0136769. PubMed ID: 26317353
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
3. Staurosporine differentiated human SH-SY5Y neuroblastoma cultures exhibit transient apoptosis and trophic factor independence.
Prince JA; Oreland L
Brain Res Bull; 1997; 43(6):515-23. PubMed ID: 9254022
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins.
Tieu K; Zuo DM; Yu PH
J Neurosci Res; 1999 Nov; 58(3):426-35. PubMed ID: 10518116
[TBL] [Abstract][Full Text] [Related]
5. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
Xie HR; Hu LS; Li GY
Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
[TBL] [Abstract][Full Text] [Related]
6. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
Jalava A; Mai S
Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020
[TBL] [Abstract][Full Text] [Related]
7. Neurosteroids enhance the viability of staurosporine and doxorubicin treated differentiated human neuroblastoma SH-SY5Y cells.
Leśkiewicz M; Regulska M; Budziszewska B; Jantas D; Jaworska-Feil L; Basta-Kaim A; Kubera M; Lasoń W
Pharmacol Rep; 2008; 60(5):685-91. PubMed ID: 19066415
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.
Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W
Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113
[TBL] [Abstract][Full Text] [Related]
9. Effects of retinoic acid and staurosporine on the protein kinase C activity and the morphology of two related human neuroblastoma cell lines.
Slack RS; Proulx P
Biochim Biophys Acta; 1990 Jun; 1053(1):89-96. PubMed ID: 2114183
[TBL] [Abstract][Full Text] [Related]
10. Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype.
Kume T; Kawato Y; Osakada F; Izumi Y; Katsuki H; Nakagawa T; Kaneko S; Niidome T; Takada-Takatori Y; Akaike A
Neurosci Lett; 2008 Oct; 443(3):199-203. PubMed ID: 18691633
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells.
Lim J; Choi HS; Choi HJ
J Neurochem; 2015 May; 133(4):544-57. PubMed ID: 25727910
[TBL] [Abstract][Full Text] [Related]
12. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line.
Magalingam KB; Radhakrishnan AK; Somanath SD; Md S; Haleagrahara N
Mol Biol Rep; 2020 Nov; 47(11):8775-8788. PubMed ID: 33098048
[TBL] [Abstract][Full Text] [Related]
13. Altered sensitivity to ellagic acid in neuroblastoma cells undergoing differentiation with 12-O-tetradecanoylphorbol-13-acetate and all-trans retinoic acid.
Alfredsson CF; Rendel F; Liang QL; Sundström BE; Nånberg E
Biomed Pharmacother; 2015 Dec; 76():39-45. PubMed ID: 26653548
[TBL] [Abstract][Full Text] [Related]
14. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
[TBL] [Abstract][Full Text] [Related]
15. Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.
Kovalevich J; Santerre M; Langford D
Methods Mol Biol; 2021; 2311():9-23. PubMed ID: 34033074
[TBL] [Abstract][Full Text] [Related]
16. Testosterone and progesterone metabolism in the human neuroblastoma cell line SH-SY5Y.
Melcangi RC; Maggi R; Martini L
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):811-8. PubMed ID: 8274416
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
18. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
[TBL] [Abstract][Full Text] [Related]
19. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
[TBL] [Abstract][Full Text] [Related]
20. Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol.
Teppola H; Sarkanen JR; Jalonen TO; Linne ML
Neurochem Res; 2016 Apr; 41(4):731-47. PubMed ID: 26518675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
